Product Image
Retatrutide (LY3437943) is a first-in-class triple hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors simultaneously. One of the most discussed research compounds in the metabolic peptide space.
Retatrutide (also known as LY3437943) is a first-in-class triple hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors simultaneously. This novel mechanism makes it one of the most discussed research compounds in the metabolic peptide space, offering a unique pharmacological profile distinct from dual agonists.
| Purity | ≥98% (HPLC) |
| Physical Form | Lyophilized powder |
| Storage | -20°C, keep away from light and moisture |
Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.
Every batch of Retatrutide sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥98% via HPLC), and the absence of heavy metals and microbial contamination.
A COA is included with every order. You may also request a batch-specific COA through our contact page.